Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia (Q40365763)
Appearance
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia |
scientific article published on October 2005 |
Statements
1 reference
Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia (English)
1 reference
David J Barnes
1 reference
Danai Palaiologou
1 reference
Eleni Panousopoulou
1 reference
Beate Schultheis
1 reference
Agnes S M Yong
1 reference
Alice Wong
1 reference
Laura Pattacini
1 reference
John M Goldman
1 reference
Junia V Melo
1 reference
1 October 2005
1 reference
1 reference
65
1 reference
19
1 reference
8912-8919
1 reference
Identifiers
1 reference
1 reference